News from Janssen Therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 21, 2017, 18:06 ET Janssen Announces U.S. FDA Approval of First and Only Complete, Single-Pill, Two-Drug Regimen, JULUCA® (Dolutegravir and Rilpivirine), for the Treatment of HIV-1 Infection $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved...


Oct 25, 2016, 08:00 ET Janssen Therapeutics Announces Funding in Support of Improved Retention in Care and Access to Treatment for Blacks and African Americans Living with HIV in Southern United States and other Rural Areas $countyNameToPathMap.put("sp

Janssen Therapeutics* announced today the recipients of funding from a special Request for Applications (RFA) to encourage comprehensive...


Jul 18, 2016, 08:00 ET U.S. FDA Approves PREZISTA® (darunavir) for Use in Pregnant Women with HIV $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has...


Mar 21, 2016, 17:00 ET Janssen Therapeutics Announces Funding for Organizations Focused on Improving Care and Treatment for Vulnerable Populations Living with HIV $countyNameToPathMap.put("sp

 Janssen today announced the recipients of funding from two special Requests for Applications (RFA) to encourage innovative models of care and...


Sep 08, 2015, 08:00 ET Your Story, Your HIV Wisdom™ Brings Together HIV Voices and Supports HIV Community Organizations $countyNameToPathMap.put("sp

Seeking and sharing information are important parts of the HIV journey – in fact, 80 percent of people living with HIV said they give advice...


Nov 05, 2014, 16:48 ET OLYSIO® (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved OLYSIO®...


Nov 25, 2013, 05:00 ET VIDEO NOW AVAILABLE: OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved...


Nov 22, 2013, 20:25 ET OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved...


Jul 16, 2013, 08:30 ET Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced today the recipient of the second scholarship the company is...


May 30, 2013, 10:00 ET Survey of Participants from Landmark GRACE Trial Provides Patients' Perspectives from an HIV Clinical Study $countyNameToPathMap.put("sp

 A survey of a segment of clinical trial participants from the GRACE (Gender, Race And Clinical Experience) trial, the largest-ever study of...


Apr 24, 2013, 08:06 ET Janssen Therapeutics LINCC™ Program Continues its Commitment to Underserved Populations with Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S. $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP, today announced the 16 organizations that will receive a charitable contribution from...


Dec 31, 2012, 09:00 ET FDA Grants Accelerated Approval for SIRTURO™ (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP, today announced the U.S. Food and Drug Administration (FDA) has granted accelerated...


Dec 10, 2012, 16:01 ET FDA Approves Prescribing Information Update for EDURANT® (rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a...


Nov 09, 2012, 17:01 ET FDA Approves New 800mg PREZISTA® (darunavir) Tablet $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration (FDA) has approved a new 800mg...


Jul 23, 2012, 08:30 ET Award-Winning Documentary, The Other City, Returns to Washington, D.C. for AIDS 2012 $countyNameToPathMap.put("sp

Women, youth and healthcare disparities are among the HIV community topics that will be discussed at screenings of the documentary film The Other...


May 29, 2012, 09:00 ET FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration (FDA) has issued a Complete...


Apr 24, 2012, 09:24 ET Watching, Reading and Listening: A New Way to Interact with Patient Information $countyNameToPathMap.put("sp

 It lies within the compact folded rectangle that accompanies prescription medicines. In black and white on paper, it follows prescription...


Apr 12, 2012, 09:00 ET Janssen Therapeutics Establishes Point Scholarship for LGBT Students $countyNameToPathMap.put("sp

Janssen Therapeutics, Division of Janssen Products, LP, is supporting education for lesbian, gay, bisexual and transgender (LGBT) students through...


Mar 27, 2012, 08:00 ET FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review $countyNameToPathMap.put("sp

 Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved...


Aug 01, 2011, 09:00 ET Stigma Remains a Significant Barrier to Routine HIV Testing by African-American Physicians, Survey Finds $countyNameToPathMap.put("sp

Social stigma is the largest barrier to routine HIV testing by African-American frontline care physicians, according to a survey commissioned...